AU2016252497A1 - Neuromodulation device - Google Patents

Neuromodulation device Download PDF

Info

Publication number
AU2016252497A1
AU2016252497A1 AU2016252497A AU2016252497A AU2016252497A1 AU 2016252497 A1 AU2016252497 A1 AU 2016252497A1 AU 2016252497 A AU2016252497 A AU 2016252497A AU 2016252497 A AU2016252497 A AU 2016252497A AU 2016252497 A1 AU2016252497 A1 AU 2016252497A1
Authority
AU
Australia
Prior art keywords
signal
nerve
patient
neural activity
smp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016252497A
Other languages
English (en)
Inventor
Daniel John CHEW
Wouter Jacob De Jonge
Hans Jakob Kristoffer FAMM
Sonal Patel
Olaf WELTING
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galvani Bioelectronics Ltd
Amsterdam UMC Location AMC
Original Assignee
Galvani Bioelectronics Ltd
Academic Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galvani Bioelectronics Ltd, Academic Medical Center filed Critical Galvani Bioelectronics Ltd
Publication of AU2016252497A1 publication Critical patent/AU2016252497A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A61N1/0556—Cuff electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016252497A 2015-04-24 2016-04-22 Neuromodulation device Abandoned AU2016252497A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562152119P 2015-04-24 2015-04-24
US62/152,119 2015-04-24
PCT/IB2016/052307 WO2016170510A1 (en) 2015-04-24 2016-04-22 Neuromodulation device

Publications (1)

Publication Number Publication Date
AU2016252497A1 true AU2016252497A1 (en) 2017-11-09

Family

ID=55963419

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016252497A Abandoned AU2016252497A1 (en) 2015-04-24 2016-04-22 Neuromodulation device

Country Status (11)

Country Link
US (2) US10974041B2 (enExample)
EP (2) EP3285856A1 (enExample)
JP (1) JP2018514354A (enExample)
KR (1) KR20180040516A (enExample)
CN (1) CN108290041A (enExample)
AU (1) AU2016252497A1 (enExample)
BR (1) BR112017022941A2 (enExample)
CA (1) CA2983652A1 (enExample)
MA (1) MA41950A (enExample)
RU (1) RU2017140776A (enExample)
WO (1) WO2016170510A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013230776B2 (en) 2012-03-08 2015-12-03 Medtronic Af Luxembourg S.A.R.L. Immune system neuromodulation and associated systems and methods
AU2015358385B2 (en) 2014-12-03 2020-09-03 Medtronic Ireland Manufacturing Unlimited Company Systems and methods for modulating nerves or other tissue
US20180193643A1 (en) * 2015-06-05 2018-07-12 The Johns Hopkins University Method and device for sacral nerve stimulation
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
PT3481284T (pt) 2016-07-07 2021-10-14 Univ California Implantes utilizando retrodifusão ultrassónica para detetar sinais eletrofisiológicos
US11633601B2 (en) 2017-12-20 2023-04-25 Galvani Bioelectronics Limited Treatment of inflammatory disorders
EP4461213A3 (en) * 2017-12-20 2025-01-08 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
CN111801137B (zh) * 2017-12-20 2024-09-06 加尔瓦尼生物电子有限公司 与炎症相关的病症的治疗
WO2019122906A1 (en) 2017-12-20 2019-06-27 Galvani Bioelectronics Limited Treatment of acute medical conditions
JP2021507762A (ja) 2017-12-20 2021-02-25 ガルバニ バイオエレクトロニクス リミテッド 急性疾患の治療
AU2019255373B2 (en) * 2018-04-19 2025-02-06 Iota Biosciences, Inc. Implants using ultrasonic communication for modulating splenic nerve activity
US11033746B2 (en) 2018-04-19 2021-06-15 Iota Biosciences, Inc. Implants using ultrasonic communication for neural sensing and stimulation
PL3843830T3 (pl) 2018-08-29 2024-08-12 Iota Biosciences, Inc. Wszczepialne urządzenie do neuromodulacji w zamkniętej pętli
US10974079B2 (en) * 2018-08-29 2021-04-13 General Electric Company Neuromodulation techniques
US12447343B2 (en) * 2018-12-20 2025-10-21 Galvani Bioelectronics Limited Neurostimulation device for blocking blood flow between electrodes
WO2020254793A1 (en) * 2019-06-19 2020-12-24 Galvani Bioelectronics Limited Treatment of acute medical conditions
US20220305259A1 (en) * 2019-06-19 2022-09-29 Galvani Bioelectronics Limited System for the Treatment of Disorders Associated with Inflammation
EP3986533A1 (en) * 2019-06-19 2022-04-27 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
KR20220082063A (ko) 2019-10-17 2022-06-16 아이오타 바이오사이언시즈 인코퍼레이티드 암 환자에서 면역 시스템 활동을 조정하고 암을 치료하기 위한 장치 및 방법
WO2021207161A1 (en) * 2020-04-09 2021-10-14 General Electric Company Non-invasive focused ultrasound neuromodulation to treat physiological conditions
WO2022122833A1 (en) * 2020-12-09 2022-06-16 Galvani Bioelectronics Limited Physiological effects of activation of the alox15 pathway
CN113197587A (zh) * 2021-04-26 2021-08-03 中国科学院深圳先进技术研究院 一种用于迷走神经刺激和电生理检测的装置及植入方法
US20250128063A1 (en) * 2021-08-10 2025-04-24 Galvani Bioelectronics Limited Neuromodulation Device
KR20230078121A (ko) * 2021-11-26 2023-06-02 주식회사 뉴라이브 동물용 미주신경 자극장치
CN114177472A (zh) * 2021-11-30 2022-03-15 中国人民解放军总医院第四医学中心 一种应用于下肢假肢的植入式电刺激感知反馈系统
US20250229086A1 (en) 2022-01-20 2025-07-17 Setpoint Medical Corporation Treatment of inflammatory disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7389145B2 (en) 2001-02-20 2008-06-17 Case Western Reserve University Systems and methods for reversibly blocking nerve activity
US20060116736A1 (en) 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US20050075702A1 (en) * 2003-10-01 2005-04-07 Medtronic, Inc. Device and method for inhibiting release of pro-inflammatory mediator
US7418292B2 (en) * 2003-10-01 2008-08-26 Medtronic, Inc. Device and method for attenuating an immune response
US8214047B2 (en) * 2004-09-27 2012-07-03 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions
EP2298410B1 (en) 2004-12-27 2013-10-09 The Feinstein Institute for Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
WO2007058780A2 (en) * 2005-11-10 2007-05-24 Electrocore, Inc. Electrical stimulation treatment of bronchial constriction
US7711430B2 (en) * 2006-02-10 2010-05-04 Electrocore Llc Methods and apparatus for treating anaphylaxis using electrical modulation
US9539425B2 (en) * 2006-10-13 2017-01-10 Intelect Medical, Inc. Systems and methods for treating medical conditions by stimulation of medial thalamic region
JPWO2008096730A1 (ja) * 2007-02-09 2010-05-20 国立大学法人名古屋大学 抗炎症剤及びその用途
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
US20120172680A1 (en) * 2010-12-28 2012-07-05 G & L Consulting, Llc Method for sympathetic rebalancing of patient
EP2707094B1 (en) * 2011-05-09 2016-02-03 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
AU2012255073B2 (en) 2011-05-19 2016-06-30 Neuros Medical, Inc. High-frequency electrical nerve block
EP2788078B1 (en) * 2011-12-09 2020-09-02 Metavention, Inc. Therapeutic neuromodulation of the hepatic system
WO2013124541A1 (en) * 2012-02-24 2013-08-29 Nokia Corporation Method and apparatus for dynamic server|client controlled connectivity logic
US11013549B2 (en) 2012-03-08 2021-05-25 Medtronic Ardian Luxembourg S.A.R.L. Gastrointestinal neuromodulation and associated systems and methods
WO2014153223A1 (en) * 2013-03-14 2014-09-25 Perryman Laura Tyler Treating inflammation, chronic pain and other disorders with neuromodulation

Also Published As

Publication number Publication date
RU2017140776A (ru) 2019-05-24
KR20180040516A (ko) 2018-04-20
US20210393949A1 (en) 2021-12-23
EP3950049A1 (en) 2022-02-09
US10974041B2 (en) 2021-04-13
US20180117319A1 (en) 2018-05-03
MA41950A (fr) 2018-02-28
EP3285856A1 (en) 2018-02-28
CN108290041A (zh) 2018-07-17
JP2018514354A (ja) 2018-06-07
BR112017022941A2 (pt) 2018-07-17
CA2983652A1 (en) 2016-10-27
WO2016170510A1 (en) 2016-10-27

Similar Documents

Publication Publication Date Title
US20210393949A1 (en) Neuromodulation device
US11872394B2 (en) Treatment of pain using electrical nerve conduction block
US9707391B2 (en) Method for modulation of effector organs
Ay et al. Electrical stimulation of the vagus nerve dermatome in the external ear is protective in rat cerebral ischemia
US20250235702A1 (en) Stimulation of a nerve supplying the spleen
US10201706B2 (en) Systems and methods of improving an inflammatory disorder
US10441787B2 (en) Neuromodulation device
JP2021507759A (ja) 炎症に関連する疾患の治療
JP2018525092A (ja) 神経調節デバイス
JP2018536453A (ja) 膀胱機能障害を処置するための状態依存的末梢神経調節
JP6796089B2 (ja) 効果器を調節するための方法および装置
EP4527445A1 (en) Electrical stimulation device
US20190201692A1 (en) Treatment of conditions associated with impaired glucose control
Mills et al. Use of Transcranial Magnetic Stimulation in the Investigation of Spinal and Transcortical

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period